Elevance Health (NYSE:ELV – Get Rating) issued an update on its FY 2023 earnings guidance on Tuesday morning. The company provided EPS guidance of $32.70- for the period, compared to the consensus EPS estimate of $32.85. The company issued revenue guidance of -. Elevance Health Stock Performance Shares of ELV stock opened at $473.14 on […]
StockNews.com assumed coverage on shares of Elevance Health (NYSE:ELV – Get Rating) in a research report sent to investors on Thursday morning. The firm issued a strong-buy rating on the stock. Several other research firms also recently issued reports on ELV. Wells Fargo & Company cut their price objective on Elevance Health from $597.00 to […]
Morgan Stanley upgraded shares of Elevance Health (NYSE:ELV – Get Rating) from an equal weight rating to an overweight rating in a research report released on Thursday, The Fly reports. The brokerage currently has $571.00 price target on the stock, up from their previous price target of $500.00. A number of other research analysts also […]
Elevance Health (NYSE:ELV – Get Rating) had its price target lowered by Wells Fargo & Company from $597.00 to $561.00 in a report issued on Monday morning, The Fly reports. Several other research analysts have also recently weighed in on the stock. Royal Bank of Canada upgraded shares of Elevance Health from a sector perform […]
Elevance Health (NYSE:ELV – Get Rating) was upgraded by investment analysts at Morgan Stanley from an “equal weight” rating to an “overweight” rating in a research note issued on Thursday, The Fly reports. The brokerage currently has a $571.00 price objective on the stock, up from their prior price objective of $500.00. Morgan Stanley’s price […]